In response to updated safety information from the U.S. Food and Drug Administration (FDA), Allergan has Voluntarily Recalled BIOCELL® Textured Breast Implants and Tissue Expanders
This action is in response to reports of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) which is an uncommon and highly treatable type of lymphoma that can develop around breast implants. The FDA’s update was attributed to a worldwide reported total of 573 unique BIA-ALCL cases including 33 deaths. BIA-ALCL is most frequently occurring in women with textured implants, Approximately 5 % of all implants in the US are textured.
Neither the FDA, nor other health authorities recommend removal or replacement of textured breast implants or tissue expanders in asymptomatic individuals.
What do we advise patients?
- Continued follow-up after any breast implant surgery is suggested and important for patient health, but patients who notice pain, lumps, swelling, fluid collections or unexpected changes in breast shape, including asymmetry should contact our office at 919-966-4446
- Know your implants. Refer to your implant card provided at the time of surgery. If you can not locate this information contact the surgeon who placed your implants. If your surgery was done at UNC contact our office and we will be happy to assist you in finding this information. The specific implants involved in this action can be found at the Allergan link below
For more information, click here for the Plastic and Reconstructive Surgery website.